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Stellingen 
1. Regulatory T cells, induced from naive T cells in vitro 
can be used either alone or together with naturally 
occurring regulatory T cells as a novel cellular therapy 
agent, in the treatment of inflammatory bowel diseases 
(IBD). 
(This thesis) 
2. Immunomodulatory proteins delivered by an adeno 
associated virus (AA V) vector based gene therapy can be 
developed as a new therapeutic modality for the 
treatment of IBD. 
(This thesis) 
3. Modulation ofT cell responses with Tregitopes may 
contribute to the design of new approaches for the 
treatment of IBD via expansion of Treg cells in vivo. 
(This thesis) 
4. Neutralizing antibodies (nAb) formed against the AA V 
vector capsid, have important implications in systemic 
AA V based gene therapy approaches, therefore a 
immunomodulatory regimen is needed and therapeutic 
strategies aimed at plasma cells demonstrate potential to 
allow for vector administration in patients with pre-
existing nAbs. 
(This thesis) 
5. It is evident that on the one hand, the immune system 
is vital for human health but that when dysregulated also 
has the capacity to kill the host. 
(Powrie F, Louis-Jeantet Prize Winner 2012, EMBO Mol 
Med 4, 71-74, DOl 10.1002/emmm.201100197) 
6. Regulatory T cells can be clinically exploited to 
control the quality and the magnitude of a wide spectrum 
of pathological and physiological immune responses. 
(Sakaguchi, S. 2008, Regulatory T cells in the past and 
for the future. Eur. J. Immunol., 38: 901-937. 
doi: 10.1 002/eji.200890012) 
7. Better understanding of genetic contributions to 
common medical conditions and reduced costs, makes it 
likely that genome sequencing at birth will replace the 
dried blood cards that are currently used for screening 
and as a result, infants with treatable predispositions 
detected by whole-genome sequencing would be offered 
an appropriate gene therapy early in life in a similar way 
to the current practice of vaccine prophylaxis against 
serious infectious pathogens. 
(Kay M.A. 2011, State-of-the-art gene-based therapies: 
the road ahead. Nature Reviews Genetics 12, 316-328 
(May 2011). doi: 10.1038/nrg2971) 
8. The basic medical sciences are not only being 
neglected, they are being systematically eroded and this 
marginalization will have damaging effects on clinical 
care over the next two decades. 
(Editorial, the Lancet, No author listed, Volume 379, 
Issue 9823, 7-13 April2012, Pages 1273) 
9. Tolerance is the highest result of education. 
(Keller H., Optimism, 1903) 
10. The patient does not care about your science; what he 
wants to know is can you cure him? 
(Fischer M.H, 1879-1962) 
